Lollar P - Search Results

1

Reduction of the antigenicity of factor VIII toward complex inhibitory antibody plasmas using multiply-substituted hybrid human/porcine factor VIII molecules.

Barrow RT, Healey JF, Gailani D, Scandella D, Lollar P. Barrow RT, et al. Among authors: lollar p. Blood. 2000 Jan 15;95(2):564-8. Blood. 2000. PMID: 10627463 Free article.

2

Coagulant properties of hybrid human/porcine factor VIII molecules.

Lollar P, Parker ET, Fay PJ. Lollar P, et al. J Biol Chem. 1992 Nov 25;267(33):23652-7. J Biol Chem. 1992. PMID: 1429706 Free article.

3

Structural basis for the decreased procoagulant activity of human factor VIII compared to the porcine homolog.

Lollar P, Parker ET. Lollar P, et al. J Biol Chem. 1991 Jul 5;266(19):12481-6. J Biol Chem. 1991. PMID: 1905722 Free article.

Following activation by thrombin, human fVIII was subjected to cation-exchange (Mono S) high performance liquid chromatography at pH 6.0 under conditions that yields stable, heterotrimeric (A1/A2/A3-C1-C2) porcine fVIIIaIIa (Lollar, P., and Parker, C.G. (1990) Bioch …

Following activation by thrombin, human fVIII was subjected to cation-exchange (Mono S) high performance liquid chromatography at pH 6.0 und …

4

Molecular characterization of commercial porcine factor VIII concentrate.

Lollar P, Parker CG, Tracy RP. Lollar P, et al. Blood. 1988 Jan;71(1):137-43. Blood. 1988. PMID: 3120820 Free article.

5

Elimination of a major inhibitor epitope in factor VIII.

Lubin IM, Healey JF, Scandella D, Runge MS, Lollar P. Lubin IM, et al. Among authors: lollar p. J Biol Chem. 1994 Mar 25;269(12):8639-41. J Biol Chem. 1994. PMID: 7510693 Free article.

6

Residues 484-508 contain a major determinant of the inhibitory epitope in the A2 domain of human factor VIII.

Healey JF, Lubin IM, Nakai H, Saenko EL, Hoyer LW, Scandella D, Lollar P. Healey JF, et al. Among authors: lollar p. J Biol Chem. 1995 Jun 16;270(24):14505-9. doi: 10.1074/jbc.270.24.14505. J Biol Chem. 1995. PMID: 7540171 Free article.

7

Immunoblot cross-reactivity of factor VIII inhibitors with porcine factor VIII.

Koshihara K, Qian J, Lollar P, Hoyer LW. Koshihara K, et al. Among authors: lollar p. Blood. 1995 Sep 15;86(6):2183-90. Blood. 1995. PMID: 7662967 Free article.

8

Inhibition by heparin of the human blood coagulation intrinsic pathway factor X activator.

Barrow RT, Parker ET, Krishnaswamy S, Lollar P. Barrow RT, et al. Among authors: lollar p. J Biol Chem. 1994 Oct 28;269(43):26796-800. J Biol Chem. 1994. PMID: 7929416 Free article.

9

Inhibition of human factor VIIIa by anti-A2 subunit antibodies.

Lollar P, Parker ET, Curtis JE, Helgerson SL, Hoyer LW, Scott ME, Scandella D. Lollar P, et al. J Clin Invest. 1994 Jun;93(6):2497-504. doi: 10.1172/JCI117259. J Clin Invest. 1994. PMID: 8200986 Free PMC article.

10

Inhibition by heparin of thrombin-catalyzed activation of the factor VIII-von Willebrand factor complex.

Barrow RT, Healey JF, Lollar P. Barrow RT, et al. Among authors: lollar p. J Biol Chem. 1994 Jan 7;269(1):593-8. J Biol Chem. 1994. PMID: 8276857 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

128 results

Search Page